SUKHTIAN GHIATH M.

Insider Reports History

Location
Amman, Jordan
Signature
/s/ Ghiath M. Sukhtian, By: Lawrence Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SUKHTIAN GHIATH M.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. Director, 10%+ Owner Common Stock 13,552,359 $18,973,302 $1.40 27 May 2025 Indirect
Outlook Therapeutics, Inc. Director, 10%+ Owner Warrants (right to buy) 8,571,428 27 May 2025 Indirect

Insider Reports Filed by SUKHTIAN GHIATH M.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 27 May 2025 2 +$6,000,000 4 Director, 10%+ Owner 28 May 2025, 17:20
OTLK Outlook Therapeutics, Inc. 17 Jan 2025 1 +$8,681,013 4/A Director, 10%+ Owner 12 Mar 2025, 20:56
OTLK Outlook Therapeutics, Inc. 18 Mar 2024 2 $0 4 Director, 10%+ Owner 20 Mar 2024, 17:20
OTLK Outlook Therapeutics, Inc. 17 Jan 2024 5 $0 4 Director, 10%+ Owner 22 Jan 2025, 16:11
OTLK Outlook Therapeutics, Inc. 28 Dec 2022 1 +$12,499,999 4 Director, 10%+ Owner 29 Dec 2022, 16:01
OTLK Outlook Therapeutics, Inc. 21 Apr 2022 1 $0 4/A Director, 10%+ Owner 07 Jul 2022, 17:27
OTLK Outlook Therapeutics, Inc. 01 Feb 2022 1 +$3,125,000 4 Director, 10%+ Owner 01 Feb 2022, 16:05
OTLK Outlook Therapeutics, Inc. 29 Nov 2021 1 +$20,000,000 4 Director, 10%+ Owner 01 Dec 2021, 18:32